Article
Dopamine D1B receptor chimeras reveal modulation of partial agonist activity by carboxyl-terminal tail sequences.
Journal of neurochemistry - 1 Dec 1998
Sugamori K S, Scheideler M A, Vernier P, Niznik H B
Abstract excerpt
NNC 01-0012, a second-generation benzazepine compound, pharmacologically differentiates multiple vertebrate D1 receptor subtypes (D1A, D1B, D1C, and D1D) and displays high selectivity and affinity for dopamine D1C receptors. Functionally, whereas NNC 01-0012 acts as a full or poor antagonist at D1C and D1A receptor-mediated cyclic AMP production, respectively, it exhibits partial agonist activity at the D1B...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
